GBGB1609770.1A
GB201609770D0
(en)
|
2016-06-03 |
2016-06-03 |
Combination therapy
|
RS20200297A
RS60211B1
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
MA051576A
MA51576A
(en)
|
2015-12-23 |
2016-12-21 |
POLYTHERAPY
|
EA201891473A
EA037459B1
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
MYPI2018001015A
MY194629A
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
HUE16820005A
HUE050290T2
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
PT168200053T
PT3393478T
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
BR112018012956-9A
BR112018012956B1
(en)
|
2015-12-23 |
2016-12-21 |
USE OF GENCITABINE-[PHENYL-(BENZOXY-L-ALANYNYL)]-PHOSPHATE OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF IN THE TREATMENT OF CANCER
|
EP16820005.3A
EP3393478B1
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
CA3008749A
CA3008749C
(en)
|
2015-12-23 |
2016-12-21 |
Treatment of ovarian cancer or biliary tract cancer with a combination of gemcitabine-(phenyl-benzoxy-l-alaninyl)]-phosphate and cisplatin
|
MDE20181039T
MD3393478T2
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
SI201630680T
SI3393478T1
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
PL16820005T
PL3393478T3
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
JP2018532746A
JP6898329B2
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
CN201680082464.9A
CN108697725A
(en)
|
2015-12-23 |
2016-12-21 |
Combination treatment
|
DK16820005.3T
DK3393478T3
(en)
|
2015-12-23 |
2016-12-21 |
combination therapy
|
US16/065,498
US20190022117A1
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
LTEP16820005.3T
LT3393478T
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
PCT/GB2016/054018
WO2017109486A1
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
KR1020187020533A
KR20180096698A
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
MEP-2020-56A
ME03677B
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
SG11201805184TA
SG11201805184TA
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
AU2016375861A
AU2016375861B2
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
ES16820005T
ES2778933T3
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
MX2018007772A
MX2018007772A
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy.
|
EP20160070.7A
EP3738595A1
(en)
|
2015-12-23 |
2016-12-21 |
Combination therapy
|
IL260076A
IL260076A
(en)
|
2015-12-23 |
2018-06-17 |
Combination therapy
|
ZA2018/04155A
ZA201804155B
(en)
|
2015-12-23 |
2018-06-21 |
Combination therapy
|
PH12018501339A
PH12018501339A1
(en)
|
2015-12-23 |
2018-06-21 |
Combination therapy
|
HK18114265.9A
HK1255110A1
(en)
|
2015-12-23 |
2018-11-08 |
Combination therapy
|
HRP20200423TT
HRP20200423T1
(en)
|
2015-12-23 |
2020-03-16 |
Combination therapy
|
CY20201100245T
CY1122835T1
(en)
|
2015-12-23 |
2020-03-17 |
COMBINED THERAPY
|
US17/845,878
US20230149436A1
(en)
|
2015-12-23 |
2022-06-21 |
Combination therapy
|